Contact
info@topadur.com+41 44 755 44 66Topadur Pharma AG
Grabenstrasse 11A
8952 Schlieren, Switzerland
Grabenstrasse 11A
8952 Schlieren, Switzerland
Read the full interview:
TOPADUR announces the submission of an application to the European Medicines Agency to receive Orphan Drug Designation Status.
Read moreTOP-N53: A Clinical Drug Candidate for the Treatment of Non-healing Wounds.
Read moreThe shareholders of the company elected today Dr. Daniel L. Vasella, as new member to the Board of Directors.
Read more
